News

It's time to talk about the horsepox synthesis and what it means for the biosecurity world and public health overall.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Both test vaccines produced immune responses by 1 month after vaccination and the immune response lasted for at least 1 year.

A pair of papers published in the Journal of Infectious Diseases highlight the effort to fight and monitor drug-resistant HIV, which poses a threat to achieving the global targets designed to end the AIDS epidemic.

Based on WHO guidelines for tuberculosis screening, many individuals who don’t have the disease are sent for expensive confirmatory testing. A simple point-of-care blood test could change all of that.

A multinational team of researchers set out to answer the following question when it comes to antiviral therapy for influenza: to combine or not to combine?

Infection prevention goes beyond healthcare workers. Here's why we should all celebrate this week.

The CDC has issued updated interim clinical guidance for healthcare providers who are caring for infants born to mothers with possible Zika virus infection during pregnancy.

A recent study has found that 1 in 9 men living in the United States have oral HPV.

A new article details how researchers are working to develop a universal flu shot.

While the northern hemisphere moves into fall, individuals in southern states must remain vigilant about Zika virus prevention.

According to reports in multiple media outlets, clinicians on the hurricane-ravaged island have already identified at least 10 cases of a rare water-borne bacterial infection, and they warn of the potential for more.

A new literature review of 60 papers and studies finds that voluntary medical male circumcision programs in Africa also have benefits for women’s health.

The pneumonic plague outbreak in Madagascar infects 684 individuals and claims 57 lives, thus far. Has it spread to Seychelles?

New research supports that allergy evaluation is an inexpensive intervention and that given the downstream benefits, it may well be cost-effective.

NIAID director Dr. Anthony S. Fauci stresses in a recent commentary that, from a practical standpoint, the development of a moderately effective HIV vaccine is “essential” to ending the pandemic.

Pandemic influenza virus strains easily infect humans and spread from person-to-person in an efficient and sustained way. With no immunity to the novel virus and no vaccine to protect against it, what will the United States do?

A total of 5 HIV cure research initiatives will receive $7.5 million as recipients of Gilead’s HIV cure grants program.

Researchers in a pediatric hospital in Tokyo see positive results following the implementation of an antibiotic stewardship program limiting carbapenem use.

The declaration was made to help direct funds towards controlling the outbreak and providing adult hepatitis A vaccines to those in need.

Recent research reveals that the composition of a woman’s vaginal microbial makeup—specifically, a preponderance of the bacteria Lactobacillus iners—may mean she’s more likely to be infected with Chlamydia trachomatis.

New tests continue to evolve that offer greater sensitivity than current methods.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Dr. Daniel Lucey provided insight on past and current yellow fever outbreaks and vaccine shortages at ID Week 2017; he also cited the very real possibility of yellow fever hitting Asia.

Researchers from the University of Colorado Boulder have developed nanoparticles capable of boosting the effectiveness of antibiotics against drug-resistant superbugs.

A recent outbreak involving sterile medical supplies gives insight into a new hospital infectious disease threat.

In any differential diagnosis of microcephaly, clinicians should consider other infections as well, depending on the setting and history of the patient.

Results from a randomized, double-blind, placebo-controlled trial show that letermovir protects from viral infection in CMV-seropositive individuals following allogeneic hematopoietic cell transplantation.